Heart Disease News and Research

Latest Heart Disease News and Research

Risk-based treatment approach should be considered for patients with hypertension

Blood pressure-lowering treatment should target patients at greatest cardiovascular risk and not just those with the highest baseline levels, suggest findings of a meta-analysis.

28 Aug 2014

Lifestyle intervention shows kidney benefits in diabetic patients

A lifestyle intervention focused on weight loss and increasing physical activity should be considered as additional treatment to prevent advanced kidney disease in overweight or obese people with Type 2 diabetes, say researchers.

28 Aug 2014

Merz Pharmaceuticals launches new CAIDE Dementia Risk App

The CAIDE Dementia Risk App from Merz Pharmaceuticals is available free of charge for people from 40 to 65 to calculate their individual risk for getting dementia within the next two decades. Using a traffic light color scheme, the App can also help physicians discuss preventive measures with patients at risk.

28 Aug 2014

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.

28 Aug 2014

Armetheon raises $7 million in first round of financing

Armetheon, Inc., a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing.

28 Aug 2014

First Edition: August 28, 2014

Today's headlines include reports about the Congressional Budget Office's latest projections regarding Medicare and Medicaid spending.

28 Aug 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, a serious lung disease that narrows the small blood vessels in the lungs.

28 Aug 2014

Receiving prescription at discharge improves outcomes in stroke patients

Stroke patients are 70 per cent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged - according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences.

28 Aug 2014

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen today announced the U.S. Food and Drug Administration has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF).

28 Aug 2014

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring is the ability to follow patients who have implantable pacemakers or defibrillators from home. This technology was introduced in the U.S. in 2001 so it’s been available for close to 15 years.

27 Aug 2014

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Asterias Biotherapeutics Inc. has received clearance from the U.S. Food and Drug Administration to initiate a Phase 1/2a clinical trial of its product, AST-OPC1, in patients with complete cervical spinal cord injury.

27 Aug 2014

Continuous positive airway pressure treatment effective for older patients with OSA

Continuous positive airway pressure is effective at treating sleep apnoea in older people, a new study has found.

27 Aug 2014

Unregulated trash burning around the globe pumps more air pollution

Unregulated trash burning around the globe is pumping far more pollution into the atmosphere than shown by official records.

27 Aug 2014

Viewpoints: Check out those nursing home stars; Rove a 'bleeding heart liberal' on Medicare?

Medicare has devised a rating system for nursing homes that portrays many of them as much better than they really are.

27 Aug 2014

New wireless monitoring sensor helps doctors and patients manage heart failure problems

Unexpected trips to the hospital are inconvenient and worrisome for anyone, but for congestive heart failure sufferers, they can be all too frequent.

27 Aug 2014

People from low socio-economic positions in Britain still eat more salt

People from low socio-economic positions in Britain still eat more salt than those from higher socio-economic positions, irrespective of where they live.

27 Aug 2014

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

27 Aug 2014

All Heart Homecare offers professional help to patients with diabetes

All Heart Homecare, a trusted Brooklyn home health care agency, is spotlighting the agency's diabetic coaching services for patients struggling with the daily monitoring and management of diabetes. Poor monitoring and maintenance of diabetes can be a fatal mistake and All Heart Homecare's staff urges all patients to learn the basics and ask for professional help when needed.

26 Aug 2014

Sorrento receives funding to advance immunotherapy targeting WISP1 for treatment of IPF

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.

26 Aug 2014

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.

26 Aug 2014

Heart Disease News and Research

Latest Heart Disease News and Research

Risk-based treatment approach should be considered for patients with hypertension

Lifestyle intervention shows kidney benefits in diabetic patients

Merz Pharmaceuticals launches new CAIDE Dementia Risk App

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Armetheon raises $7 million in first round of financing

First Edition: August 28, 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Receiving prescription at discharge improves outcomes in stroke patients

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Continuous positive airway pressure treatment effective for older patients with OSA

Unregulated trash burning around the globe pumps more air pollution

Viewpoints: Check out those nursing home stars; Rove a 'bleeding heart liberal' on Medicare?

New wireless monitoring sensor helps doctors and patients manage heart failure problems

People from low socio-economic positions in Britain still eat more salt

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

All Heart Homecare offers professional help to patients with diabetes

Sorrento receives funding to advance immunotherapy targeting WISP1 for treatment of IPF

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in